Clinical Trials on Glabellar Crease in New Zealand

Total 2404 results

Alison Stopeck
Eli Lilly and Company; AstraZeneca

Withdrawn

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Locally Advanced Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female

United States
Roswell Park Cancer Institute
National Center for Advancing Translational Sciences (NCATS)

Completed

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic... and other conditions

United States
Daiichi Sankyo

Completed

Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan

HER2-positive Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC) (TRAC)

Breast Cancer Survivors

United States
Weill Medical College of Cornell University

Recruiting

De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You (DIGNITY)

Breast Cancer

United States
Weill Medical College of Cornell University

Recruiting

Combined Immunotherapies in Metastatic ER+ Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
The City College of New York

Active, not recruiting

Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer

Breast Cancer

United States
NYU Langone Health

Active, not recruiting

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

Breast Cancer

United States
NYU Langone Health

Active, not recruiting

Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer

Breast Cancer

United States
Pfizer

Completed

RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Breast Cancer

United States
Pfizer

Completed

Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
Columbia University
Breast Cancer Research Foundation

Completed

Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation

Breast Cancer

United States
Columbia University
National Cancer Institute (NCI)

Completed

Diet and Physical Activity Changes Among Latina Breast Cancer Survivors

Breast Cancer

United States
Icahn School of Medicine at Mount Sinai
AstraZeneca

Terminated

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Breast Cancer

United States
Taipei Medical University Shuang Ho Hospital

Completed

Impact of Decision Aids on Breast Cancer Surgery Choice: A Randomized Controlled Trial

Breast Cancer

Taiwan
Katherine D. Crew
Prevent Cancer Foundation

Completed

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

Breast Cancer

United States
NYU Langone Health

Terminated

Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer (Cu-64 HER2+)

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
United States Department of Defense

Completed

Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer

Breast Cancer

United States
Icahn School of Medicine at Mount Sinai

Completed

Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities

Breast Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and...

Terminated

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Breast Cancer

United States
New York Presbyterian Hospital

Unknown

Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women

Breast Cancer

United States
Deborah Doroshow

Recruiting

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Lobular Breast Carcinoma | Metastatic Breast Carcinoma | Metastatic Lobular Breast Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

Invasive Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

Invasive Breast Cancer | Post-mastectomy

United States
Oncolytics Biotech
PrECOG, LLC.

Active, not recruiting

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Breast Cancer Metastatic

United States
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

Breast Cancer

United States
Roswell Park Cancer Institute

Terminated

Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors

Obesity | Overweight | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast... and other conditions

United States
Memorial Sloan Kettering Cancer Center

Completed

Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction

Breast Cancer | Breast Cancer Female

United States
University Hospitals of Derby and Burton NHS Foundation...
University of Nottingham; Breast Cancer Trials, Australia and New Zealand; Sussex... and other collaborators

Active, not recruiting

POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer (POSNOC)

Breast Cancer

United Kingdom, New Zealand, Australia
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Breast Cancer | Locally Advanced Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

Breast Cancer | Breast Carcinoma

United States
SenoRx, Inc.
C. R. Bard

Terminated

Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB

Breast Cancer

United States
NYU Langone Health

Completed

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Breast Cancer

United States
Neovii Biotech
Fresenius Biotech North America

Terminated

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy

Advanced Breast Cancer | Metastatic Breast Cancer

United States, Canada
Memorial Sloan Kettering Cancer Center
United States Department of Defense

Active, not recruiting

T-Cell Therapy for Advanced Breast Cancer

Breast Cancer | Metastatic HER2-negative Breast

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Enrolling by invitation

Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care

Cancer, Breast | Health Care Utilization

United States
Memorial Sloan Kettering Cancer Center

Completed

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer

Recurrent Breast Carcinoma | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Bilateral Breast Carcinoma | Localized Breast Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Factors Associated With Breast Cancer Risks and Outcomes

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Yale University; Weill Medical College of Cornell University; New York Presbyterian...

Recruiting

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Novartis

Completed

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline

Completed

Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model

Breast Cancer

United States

Clinical Trials on Glabellar Crease in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations